Cantata Bio

Cantata Bio

Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $30.2M

Overview

Cantata Bio (Dovetail Genomics) is a private, revenue-generating platform company focused on advanced genomics. Its core innovation is the Dovetail® LinkPrep™ technology, a linked-read assay that uses proximity ligation to preserve spatial DNA relationships, overcoming the limitations of short-read sequencing. This platform enables applications across genome assembly, 3D genomics, and genetic variation analysis, positioning the company as a key enabler for complex genomic research in academia and biopharma. The company operates as part of the EdenRoc Sciences ecosystem and distributes its products globally.

Genetics & Genomics

Technology Platform

Dovetail® LinkPrep™ linked-read technology using proximity ligation to capture long-range genomic and 3D chromatin interaction information from short-read sequencing data.

Funding History

4
Total raised:$30.2M
Grant$1.2M
Series A$20M
Seed$5M
Seed$4M

Opportunities

Growing demand for comprehensive variant detection in cancer genomics and rare disease research presents a major opportunity.
The expansion of spatial/3D genomics as a core research area in epigenetics and gene regulation creates a new, high-growth application vertical for the platform.

Risk Factors

Competition from native long-read sequencing technologies (PacBio, Oxford Nanopore) and other proximity ligation methods is intense.
The company's growth is dependent on convincing researchers to adopt a specialized library prep method in a crowded NGS workflow ecosystem.

Competitive Landscape

Competes directly with long-read sequencing platforms (PacBio, Oxford Nanopore) for genome assembly and variant detection. Faces competition in 3D genomics from dedicated Hi-C service providers and kit manufacturers (e.g., Arima Genomics, Phase Genomics). Also competes within the broader NGS enrichment and sample prep market dominated by large players like Illumina.